INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 24, 2015 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 3,000 |
Feb 24, 2015 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
Feb 24, 2015 |
Director
Trans History: 320
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 10,000 |
Feb 24, 2015 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Other acquisition or disposition | -- | -- | 1,426 |
Feb 23, 2015 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 18,349 |
Feb 18, 2015 |
SVP Strategy Investor Relation
Trans History: 164
|
SVP Strategy Investor Relation | Form 4 | Other acquisition or disposition | -- | -- | 376 |
Jan 05, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 18,000 |
Jan 05, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,621 |
Jan 05, 2015 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,650 |
Jan 05, 2015 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 42,087 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.